No CrossRef data available.
Article contents
Dosimetric comparison of Synchrony® real-time motion tracking treatment plans between CyberKnife robotic radiosurgery and Radixact system for stereotactic body radiation therapy of lung and prostate cancer
Published online by Cambridge University Press: 21 April 2022
Abstract
The aim of this study was to assess which machine, Radixact or CyberKnife, can deliver better treatment for lung and prostate stereotactic body radiation therapy (SBRT) with the use of Synchrony® real-time motion tracking system. Ten and eight patients treated with lung and prostate SBRT, respectively, using the CyberKnife system were selected for the assessment. For each patient, a retrospective Radixact plan was created and compared with the original CyberKnife plan. There was no statistically significant difference in the new conformity index of the Radixact plans and that of the Cyberknife plans in both lung and prostate SBRT. The average homogeneity index in the Radixact plans was better in both lung and prostate SBRT with statistical significance (p = 0·04 for lung and p = 0·02 for prostate). In lung SBRT, the dose to lungs was lower in Cyberknife plans (p = 0·002). In prostate SBRT, there was no statistically significant difference in organs at risk sparing between Cyberknife plans and Radixact plans. In conclusion, CyberKnife was better in lung SBRT while Radixact was better in prostate SBRT.
- Type
- Technical Note
- Information
- Copyright
- © The Author(s), 2022. Published by Cambridge University Press
References
Katz, A. Stereotactic body radiotherapy for low-risk prostate cancer: a ten-year analysis. Cureus 2017; 9 (9): e1668.Google ScholarPubMed
Singh, D, Chen, Y, Bergsma, D P et al. Local control rates with five fractions of stereotactic body radiotherapy for primary lung tumors: a single institution experience of 153 consecutive patients. Trans Cancer Res 2015; 4 (4): 332–339.Google Scholar
Bei, Y, Murakami, N, Nakayama, Y et al. Stereotactic body radiation therapy for early-stage non–small-cell lung cancer in octogenarians and older: an alternative treatment. J Radiat Res 2020; 61, (4): 586–593.CrossRefGoogle Scholar
Amin, S A, Alam, M, Baine, M J, Meza, J L, Bennion, N R, Zhang, C, Rahman, I, Lin, C. The impact of stereotactic body radiation therapy on the overall survival of patients diagnosed with early-stage non-small cell lung cancer. Radiother Oncol 2021; 155: 254–260.CrossRefGoogle ScholarPubMed
Kennedy, W R, Gabani, P, Nikitas, J, Robinson, C G, Bradley, J D, Roach, M C, Repeat stereotactic body radiation therapy (SBRT) for salvage of isolated local recurrence after definitive lung SBRT. Radiother Oncol 2020; 142: 230–235.CrossRefGoogle ScholarPubMed
Huang, E, Dong, L, Chandra, A, Kuban, D A, Rosen, I I, Evans, A, Pollack, A, Intrafraction prostate motion during IMRT for prostate cancer. Int J Radiat Oncol Biol Phys 2002; 53 (2): 261–268.CrossRefGoogle ScholarPubMed
Quirk, S, Becker, N, and Smith, W L. External respiratory motion analysis and statistics for patients and volunteers. J Appl Clin Med Phys 2013; 14 (2): 90–101.CrossRefGoogle ScholarPubMed
Kurup, G. CyberKnife: a new paradigm in radiotherapy. J Med Phys 2010; 35 (2): 63–64.CrossRefGoogle ScholarPubMed
Sumida, I, Shiomi, H, Higashinaka, N et al. Evaluation of tracking accuracy of the CyberKnife system using a webcam and printed calibrated grid. J Appl Clin Med Phys 2016; 17 (2): 74–84.CrossRefGoogle ScholarPubMed
Schnarr, E, Beneke, M, Casey, D et al. Feasibility of real-time motion management with helical tomotherapy. Med Phys 2018; 45 (4): 1329–1337.CrossRefGoogle ScholarPubMed
Ferris, W S, Kissick, M W, Bayou, J E, Culberson, W S, Smilowitz, J B. Evaluation of radixact motion synchrony for 3D respiratorymotion: modeling accuracy and dosimetric fidelity. J Appl Clin Med Phys 2020; 21 (9): 96–106.CrossRefGoogle Scholar
Lee, T-F, Fang, F-M, Chao, P-J, Su, T-J, Wang, L K, Leung, S W. Dosimetric comparisons of helical tomotherapy and step-and-shoot intensity-modulated radiotherapy in nasopharyngeal carcinoma. Radiother Oncol 2008; 89 (1): 89–96.CrossRefGoogle ScholarPubMed
Benedict, SH, Yenice, KM, Followill, D et al. Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys 2010; 37 (8): 4078–4101.CrossRefGoogle ScholarPubMed
Lukka, H, Bahary, J, Lawton, C et al. A randomized phase II trial of hypofractionated radiotherapy for favorable risk prostate cancer - RTOG CCOP Study. NRG Oncol. 2015, ClinicalTrials.gov. Identifier: NCT01434290.Google Scholar
Oliver, M, Chen, J, Wong, E, Dyk, J V, Perera, F. A treatment planning study comparing whole breast radiation therapy against conformal, IMRT and tomotherapy for accelerated partial breast irradiation. Radiother Oncol 2007; 82 (3): 317–323.CrossRefGoogle ScholarPubMed
Paddick, I, Lippitz, B. A simple dose gradient measurement tool to complement the conformity index. J Neurosurg 2006; 105 (Suppl): 194–201.CrossRefGoogle ScholarPubMed
Scobioala, S, Kittel, C, Elsayad, K, Kroeger, K, Oertel, M, Samhouri, L, Haverkamp, U, Eich, H T. A treatment planning study comparing IMRT techniques and cyber knife for stereotactic body radiotherapy of low-risk prostate carcinoma. Radiat Oncol 2019; 14: 143.CrossRefGoogle ScholarPubMed
De Armas. Impact of intrafractional prostate motion on the accuracy and efficiency of prostate cancer treatment on Cyberknife radiotherapy. MIT Thesis, 2015. https://dspace.mit.edu/handle/1721.1/98920.Google Scholar
Chen, G, Tai, A, Keiper, T D., Lim, S, Li, A. X Technical note: comprehensive performance tests of the first clinical real-time motion tracking and compensation system using MLC and jaws. Med Phys 2020; 47 (7): 2814–2825.CrossRefGoogle ScholarPubMed